Mozambican political parties with parliamentary seats have called the attack on a supporter of Venâncio Mondlane "political ...

Poole-based property finance business MSP Capital has appointed a former banking chief as its new CEO. Leigh Bartlett has ...

Ball reported financial relationships with the Alberta Health Services Chair in Obesity Research, the Canadian Institutes of ...

This summary of health news briefs includes reports on how the U.S.-China trade war impacts drug costs, EU approval of ...

Pfizer decided to abort the clinical trial of its daily weight loss pill 'Danuglipron' after one patient in a trial showed signs of liver damage, likely to be caused by the drug.

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ: VKTX), the turbulence has been extremely challenging thus far. The stock ...

Pfizer PFE announced that it is discontinuing the development of danuglipron, its investigational oral GLP-1 receptor agonist (GLP-1 RA), which is being developed to treat obesity. The decision ...

Russian President Vladimir Putin attends a meeting on the development of infrastructure for life via videoconference at the Novo-Ogaryovo state residence outside Moscow, Russia, Tuesday, April 15, ...

Its statement also suggested the patient’s liver enzymes were elevated. That often is indicative of damage to cells in the organ, according to the Cleveland Clinic. Pfizer told CNBC that the trial ...

European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 1.05% to 1,344.05 on the S&P Europe Select ADR Index. From continental Europe, the ...

Shares of Novo Nordisk, Eli Lilly, Structure Therapeutics and Viking Therapeutics gain as PFE abandons development of its ...